“Driving the growth and development of FreseniusRx services to help support positive patient outcomes through integrated care with dialysis clinics and physicians.”
As the president of FreseniusRx, Dr. Randell (RJ) Correia, PharmD, oversees the planning and execution of our FreseniusRx service and growth strategies. He is committed to fostering a high-performing pharmacy team with a patients-first mindset.
Dr. Correia has a deep background in pharmacy leadership roles across various organizations, including experience in pharmacy benefit management, specialty and mail-service pharmacy. Most recently, he was founder and consultant at KNR Enterprises, LLC, where he advised private equity and venture capital firms on managed care and specialty pharmacy businesses. Prior to that he served as President & COO of US Script (Centene Corporation’s Pharmacy Benefit Manager) where he led 300 employees and $2.2 billion in annual revenue. Dr. Correia spent 11 years leading the mail service and specialty pharmacy service businesses of OptumRx (formerly Prescription Solutions and now owned by UnitedHealth Care) as Senior Vice President. At OptumRx, he led 2,800 employees generating $4.4 billion annually.
Dr. Correia currently serves on academic and industry governing boards and advisory councils, including University of the Pacific Governing Boards for the school’s Pharmacy Entrepreneurial Practice Program, Dean’s Advisory Council, Brand Advisory Committee, and health sciences multi-disciplinary continuing education development board. Dr. Correia was previously a member of the Pharmaceutical Care Management Association (PCMA) Specialty Pharmacy Board and is a nationally recognized expert, author and editorial board member for a leading Specialty Pharmacy magazine.
Dr. Correia completed his Doctor of Pharmacy from the University of the Pacific in Stockton, CA, and a clinical residency at Holy Cross Hospital in Florida.